Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast

被引:89
作者
Berclaz, G
Altermatt, HJ
Rohrbach, V
Kieffer, I
Dreher, E
Andres, AC
机构
[1] Univ Bern, Univ Hosp, Dept Obstet & Gynecol, Bern, Switzerland
[2] Univ Bern, Dept Clin Res, Bern, Switzerland
关键词
apoptosis; breast cancer; estrogen receptors; immunohistochemistry;
D O I
10.1023/A:1011126330233
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Axl, a member of a family of receptor tyrosine kinases characterized by an extracellular domain resembling cell adhesion molecules and an intracellular conserved tyrosine kinase domain has been reported to induce cell proliferation and transformation. In mice, axl is expressed in the normal mammary gland and over-expressed in aggressive mammary tumors. Patients and methods: We have investigated the expression of axl immunohistochemically in 23 normal human breast samples and in 111 consecutive breast carcinomas. Expression of axl was correlated with tumour characteristics (lymph node involvement, stage, grade) and immunohistochemical expression of ER, PR, Ki-67 and c-erbB-2. Results: In normal tissue, axl localizes to the membrane of breast epithelial cells. Axl protein shows membrane associated staining in high correlation (P = 0.004) with the expression of the estrogen receptor (ER). Axl expression was found in a subset of breast carcinomas and was also correlated with high significance (P < 0.0001) with the presence of ER. Conclusion: Our results suggest that axl may serve as a mediator of estrogen stimulation preventing the completion of the breast epithelial life cycle and that estrogen induced axl expression may give a survival signal to cancerous cells, preventing them from dying through apoptosis.
引用
收藏
页码:819 / 824
页数:6
相关论文
共 35 条
[1]  
ANDERSON CH, 1992, CANCER RES, V52, P5076
[2]   Changes in the normal human breast throughout the menstrual cycle: Relevance to breast carcinogenesis [J].
Anderson, E ;
Clarke, RB ;
Howell, A .
ENDOCRINE-RELATED CANCER, 1997, 4 (01) :23-33
[3]   PROTEIN-TYROSINE KINASE EXPRESSION DURING THE ESTROUS-CYCLE AND CARCINOGENESIS OF THE MAMMARY-GLAND [J].
ANDRES, AC ;
ZUERCHER, G ;
DJONOV, V ;
FLUECK, M ;
ZIEMIECKI, A .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (02) :288-296
[4]   Apoptosis in the estrous and menstrual cycles [J].
Andres, AC ;
Strange, R .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1999, 4 (02) :221-228
[5]   Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation [J].
Bellosta, P ;
Zhang, Q ;
Goff, SP ;
Basilico, C .
ONCOGENE, 1997, 15 (20) :2387-2397
[6]  
BELLOSTA P, 1995, MOL CELL BIOL, V15, P614
[7]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[8]   Expression of the receptor protein tyrosine kinase myk-1/htk in normal and malignant mammary epithelium [J].
Berclaz, G ;
Andres, AC ;
Albrecht, D ;
Dreher, E ;
Ziemiecki, A ;
Gusterson, BA ;
Crompton, MR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 226 (03) :869-875
[9]  
Berclaz G, 2000, INT J CANCER, V85, P889
[10]   EFFECT OF ENDOCRINE THERAPY ON GROWTH OF T61 HUMAN BREAST-CANCER XENOGRAFTS IS DIRECTLY CORRELATED TO A SPECIFIC DOWN-REGULATION OF INSULIN-LIKE GROWTH FACTOR-II (IGF-II) [J].
BRUNNER, N ;
YEE, D ;
KERN, FG ;
SPANGTHOMSEN, M ;
LIPPMAN, ME ;
CULLEN, KJ .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (04) :562-569